@dansfera: When government regulation oversteps into the tools meant to make life easier for clinical trial workers, innovation often hits a brick wall. The FDA might be well-intentioned, but by clamping down on efficiency-focused tech like Gleam—which exists purely to streamline data and lighten the load for staff—the industry risks shooting itself in the foot. Instead of protecting patients, are these rules actually holding back the very processes designed to create faster, data-driven breakthroughs? #ClinicalTrials #FDA #HealthTech #MedicalInnovation #BioTech